Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.WT

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 3rd quarter

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Jun 25, 2024 8:30pm

146 Views

Post# 36106130

RE:RE:RE:RE:RE:RE:3rd quarter

Good insights, Eoganacht.Took a look at LabCorp.com , page titled What Does A central Lab Do? In this case, if the FDA requested them to take every result and replicate it at one of these labs, there must be some concern about process variability across CSS sites, despite RDWs comments to the effect of being surprised by this ask. The conspiracy theory types may blame "big pharma". It would have been helpful to know if that is the only issue preventing them from submitting the data, and thus being stuck in an endless PP loop.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects